Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: Relationship with central serotonin turnover

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 83, Issue 4-6, 2010, Pages 185-191

  McNamara, Robert K ^a   Jandacek, Ronald ^a   Rider, Therese ^a   Tso, Patrick ^a   Cole Strauss, Allyson ^a,b   Lipton, Jack W ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Arachidonic acid; Brain; C reactive protein; Cytokines; Docosahexaenoic acid (DHA); Erythrocyte; Inflammation; Omega 3 fatty acids; Rats; Serotonin

Indexed keywords

ARACHIDONIC ACID; BRAIN MONOAMINE; C REACTIVE PROTEIN; INTERLEUKIN 6; LINOLENIC ACID; OMEGA 6 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; ERYTHROCYTE; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID SYNTHESIS; FEMALE; IN VIVO STUDY; LIPID COMPOSITION; MALE; MONOAMINE RELEASE; NONHUMAN; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SEROTONIN METABOLISM; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; THERAPY EFFECT; UPREGULATION; WEANING;

ALPHA-LINOLENIC ACID; ANIMALS; C-REACTIVE PROTEIN; CYTOKINES; FATTY ACIDS, OMEGA-3; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPIDS; MALE; RATS; RATS, LONG-EVANS; SEROTONIN; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 78649447062     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.08.004     Document Type: Article

References (30)

1. Calder P.C. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79:101-108.
2. Groeger A.L., Cipollina C., Cole M.P., Woodcock S.R., Bonacci G., Rudolph T.K., Rudolph V., Freeman B.A., Schopfer F.J. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat. Chem. Biol. 2010, 6:433-441.
3. Khalfoun B., Thibault F., Watier H., Bardos P., Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv. Exp. Med. Biol. 1997, 400:589-597.
4. Serhan C.N. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr. Opin. Clin. Nutr. Metab. Care 2005, 8:115-121.
5. Song C., Li X., Leonard B.E., Horrobin D.F. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. J. Lipid Res. 2003, 44:1984-1991.
6. Mingam R., Moranis A., Bluthé R.M., De Smedt-Peyrusse V., Kelley K.W., Guesnet P., Lavialle M., Dantzer R., Layé S. Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice. Eur. J. Neurosci. 2008, 28:1877-1886.
7. Ferrucci L., Cherubini A., Bandinelli S., Bartali B., Corsi A., Lauretani F., Martin A., Andres-Lacueva C., Senin U., Guralnik J.M. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 2006, 91:439-446.
8. Micallef M.A., Munro I.A., Garg M.L. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur. J. Clin. Nutr. 2009, 63:1154-1156.
9. Assies J., Pouwer F., Lok A., Mocking R.J., Bockting C.L., Visser I., Abeling N.G., Duran M., Schene A.H. Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS One 2010, 5:10635.
10. Edwards R., Peet M., Shay J., Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affect. Disord. 1998, 48:149-155.
11. Maes M., Christophe A., Delanghe J., Altamura C., Neels H., Meltzer H.Y. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999, 85:275-291.
12. R.K. McNamara, R. Jandacek, T. Rider, P. Tso, Y. Dwivedi, G.N. Pandey, Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder, J. Affect. Disord. 2010 [Epub ahead of print].
13. Peet M., Murphy B., Shay J., Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry 1998, 43:315-319.
14. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., LanctÔt K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
15. Kling M.A., Alesci S., Csako G., Costello R., Luckenbaugh D.A., Bonne O., Duncko R., Drevets W.C., Manji H.K., Charney D.S., Gold P.W., Neumeister A. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol. Psychiatry 2007, 62:309-313.
16. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
17. Igarashi M., Ma K., Chang L., Bell J.M., Rapoport S.I. Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain. J. Lipid Res. 2007, 48:2463-2470.
18. Moriguchi T., Loewke J., Garrison M., Catalan J.N., Salem N. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J. Lipid Res. 2001, 42:419-427.
19. Obukowicz M.G., Welsch D.J., Salsgiver W.J., Martin-Berger C.L., Chinn K.S., Duffin K.L., Raz A., Needleman P. Novel, selective delta6 or delta5 fatty acid desaturase inhibitors as antiinflammatory agents in mice. J. Pharmacol. Exp. Ther. 1998, 287:157-166.
20. Portanova J.P., Zhang Y., Anderson G.D., Hauser S.D., Masferrer J.L., Seibert K., Gregory S.A., Isakson P.C. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. 1996, 184:883-891.
21. Wang P., Zhu F., Konstantopoulos K. Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation. Am. J. Physiol. Cell Physiol. 2010, 298:1445-1456.
22. Rao J.S., Ertley R.N., DeMar J.C., Rapoport S.I., Bazinet R.P., Lee H.J. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol. Psychiatry 2007, 12:151-157.
23. Kodas E., Galineau L., Bodard S., Vancassel S., Guilloteau D., Besnard J.C., Chalon S. Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J. Neurochem. 2004, 89:695-702.
24. McNamara R.K., Able J.A., Liu Y., Jandacek R., Rider T., Tso P., Lipton J.W. Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects. J. Psychiatry Res. 2009, 43:656-663.
25. Wang J, Dunn A.J. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem. Int. 1998, 33:143-154.
26. Zhang J., Terreni L., De Simoni M.G., Dunn A.J. Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum. Neurochem. Int. 2001, 38:303-308.
27. McNamara R.K., Sullivan J., Richtand N.M. Omega-3 fatty acid deficiency augments the development of behavioral sensitization in adult mice: prevention by chronic lithium treatment. J. Psychiatr. Res. 2008, 42:458-468.
28. Barton D.A., Esler M.D., Dawood T., Lambert E.A., Haikerwal D., Brenchley C., Socratous F., Hastings J., Guo L., Wiesner G., Kaye D.M., Bayles R., Schlaich M.P., Lambert G.W. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch. Gen. Psychiatry 2008, 65:38-46.
29. Sheline Y., Bardgett M.E., Csernansky J.G. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors. J. Clin. Psychopharmacol. 1997, 17:11-14.
30. McNamara R.K. Membrane omega-3 fatty acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder. Cardiovasc. Psychiatry Neurol. 2009, 9:1-13.